Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 25 11:04AM ET
112.70
Dollar change
-3.73
Percentage change
-3.20
%
IndexRUT P/E- EPS (ttm)-4.04 Insider Own1.79% Shs Outstand30.95M Perf Week0.52%
Market Cap3.49B Forward P/E- EPS next Y-1.74 Insider Trans-9.22% Shs Float30.42M Perf Month-2.00%
Income-123.41M PEG- EPS next Q-0.97 Inst Own107.34% Short Float9.25% Perf Quarter-4.66%
Sales492.68M P/S7.09 EPS this Y29.15% Inst Trans0.46% Short Ratio6.32 Perf Half Y40.38%
Book/sh6.79 P/B16.60 EPS next Y39.35% ROA-28.00% Short Interest2.81M Perf Year-16.43%
Cash/sh4.32 P/C26.10 EPS next 5Y- ROE-54.86% 52W Range70.24 - 138.64 Perf YTD5.29%
Dividend Est.- P/FCF- EPS past 5Y-13.90% ROI-38.00% 52W High-18.71% Beta1.30
Dividend TTM- Quick Ratio2.02 Sales past 5Y27.64% Gross Margin67.35% 52W Low60.45% ATR (14)4.26
Dividend Ex-Date- Current Ratio2.15 EPS Y/Y TTM-3.82% Oper. Margin-23.16% RSI (14)50.92 Volatility3.46% 3.78%
Employees2000 Debt/Eq0.62 Sales Y/Y TTM19.90% Profit Margin-25.05% Recom1.25 Target Price138.50
Option/ShortYes / Yes LT Debt/Eq0.55 EPS Q/Q-88.16% Payout- Rel Volume0.27 Prev Close116.43
Sales Surprise1.78% EPS Surprise-117.73% Sales Q/Q17.67% EarningsMay 02 AMC Avg Volume444.95K Price112.70
SMA200.02% SMA501.18% SMA20011.23% Trades Volume33,914 Change-3.20%
Date Action Analyst Rating Change Price Target Change
Dec-11-23Upgrade Citigroup Neutral → Buy $110
Jul-19-23Initiated Robert W. Baird Outperform $130
Feb-07-23Initiated Wells Fargo Overweight $150
Nov-07-22Upgrade Wolfe Research Underperform → Peer Perform
Jun-09-22Downgrade Citigroup Buy → Neutral $180 → $155
Apr-06-22Initiated Wolfe Research Underperform $105
Feb-24-22Upgrade Needham Hold → Buy $135
Feb-24-22Upgrade Needham Hold → Buy
Jan-18-22Upgrade Morgan Stanley Equal-Weight → Overweight $129 → $167
Jan-12-22Upgrade BTIG Research Neutral → Buy $170
Apr-23-24 12:35PM
Apr-18-24 04:05PM
Apr-08-24 04:09AM
Apr-01-24 05:45AM
Mar-20-24 05:45AM
11:30AM Loading…
Mar-13-24 11:30AM
Mar-08-24 04:30PM
Mar-05-24 11:29PM
Mar-04-24 11:42PM
06:45AM
Feb-29-24 04:30PM
Feb-23-24 12:30PM
11:06AM
05:45AM
Feb-22-24 05:50PM
04:36PM Loading…
04:36PM
04:05PM
Feb-20-24 01:59PM
05:45AM
Feb-08-24 04:05PM
Jan-14-24 12:54PM
Jan-08-24 08:30AM
Jan-05-24 08:05AM
Jan-04-24 07:01PM
Jan-03-24 08:00AM
Dec-26-23 04:30PM
Nov-13-23 08:05AM
Nov-03-23 10:41AM
09:44AM
Nov-02-23 06:22PM
04:05PM Loading…
04:05PM
Oct-31-23 10:01AM
Oct-27-23 09:35AM
Oct-26-23 10:02AM
Oct-19-23 04:05PM
Sep-28-23 08:23AM
Sep-27-23 07:35PM
Sep-26-23 08:05AM
Sep-22-23 11:47AM
Aug-29-23 08:30AM
Aug-23-23 06:00AM
Aug-04-23 10:45AM
Aug-03-23 05:55PM
04:10PM
04:05PM
Jul-26-23 04:24PM
Jul-20-23 04:05PM
Jul-18-23 08:30AM
Jun-14-23 09:23AM
Jun-06-23 09:00AM
May-27-23 08:28AM
May-24-23 04:05PM
May-22-23 08:30AM
May-11-23 06:09AM
May-04-23 06:05PM
04:05PM
Apr-20-23 04:05PM
Apr-14-23 06:51PM
Apr-13-23 12:21PM
Apr-12-23 04:30PM
Apr-02-23 02:07PM
Mar-14-23 07:42AM
Mar-06-23 08:30AM
Mar-02-23 08:30AM
Feb-25-23 08:04AM
Feb-24-23 02:44PM
Feb-23-23 04:05PM
Feb-21-23 06:57AM
Feb-09-23 04:05PM
Jan-09-23 08:30AM
Dec-27-22 04:30PM
Dec-01-22 01:54PM
Nov-14-22 10:43AM
Nov-07-22 04:05PM
Nov-06-22 12:30PM
Nov-04-22 11:47AM
Nov-02-22 05:45PM
08:30AM
06:28AM
Nov-01-22 05:45PM
04:05PM
Oct-20-22 04:05PM
Sep-21-22 08:30AM
Aug-31-22 08:30AM
Aug-06-22 05:00AM
Aug-05-22 10:27AM
Aug-04-22 07:15PM
04:05PM
Jul-28-22 04:30PM
10:02AM
Jul-25-22 04:15PM
Jul-22-22 04:52PM
08:30AM
Jul-18-22 04:10PM
Jul-08-22 08:30AM
Jun-27-22 07:38AM
Jun-19-22 09:03AM
May-25-22 04:05PM
May-06-22 04:11PM
11:00AM
iRhythm Technologies, Inc. is a digital healthcare company, which engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blackford Quentin S.President and CEOMar 04 '24Sale111.144,221469,122175,794Mar 05 04:52 PM
Day Mark J.Chief Technology OfficerMar 04 '24Sale111.143,248360,98361,164Mar 05 04:53 PM
Wilson Daniel G.EVP, Corp Dev Inv RelMar 04 '24Sale111.142,452272,51530,515Mar 05 04:50 PM
Bobzien BriceChief Financial OfficerMar 04 '24Sale111.141,401155,70725,800Mar 05 04:50 PM
Patterson ChadChief Commercial OfficerMar 04 '24Sale111.141,077119,69839,865Mar 05 04:52 PM
Turakhia MinangEVP, CMO & CSOMar 04 '24Sale111.14943104,80528,659Mar 05 04:50 PM
Shrishrimal SumiEVP, Chief Risk OfficerMar 04 '24Sale111.1472380,35424,429Mar 05 04:49 PM
Blackford Quentin S.President and CEOFeb 29 '24Sale121.9624,7013,012,534180,015Mar 01 07:19 PM
Murphy Patrick MichaelCBO and CLOFeb 29 '24Sale121.967,615928,72548,962Mar 01 07:19 PM
Day Mark J.Chief Technology OfficerFeb 29 '24Sale121.961,475179,89164,412Mar 01 07:18 PM
Wilson Daniel G.EVP, Corp Dev Inv RelFeb 29 '24Sale121.961,261153,79232,967Mar 01 07:18 PM
Wilson Daniel G.EVP, Corp Dev Inv RelJan 02 '24Sale103.317,218745,69226,629Jan 04 11:57 AM
Bobzien BriceChief Financial OfficerAug 09 '23Sale111.291,356150,90918,608Aug 10 04:20 PM
Day Mark J.Chief Technology OfficerAug 03 '23Option Exercise36.2248617,60355,522Aug 04 08:48 AM
Shrishrimal SumiEVP, Chief Risk OfficerJun 02 '23Sale111.451,109123,59818,707Jun 05 04:07 PM